MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • MDS Virtual Congress 2021

    Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort

    A. Neji, A. Nasri, I. Sghaier, S. Mrabet, M. Bendjebara, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To investigate survival and its determinants in a Tunisian cohort of Progressive Supranuclear Palsy (PSP). Background: PSP is a neurodegenerative tauopathy characterized by faster…
  • MDS Virtual Congress 2021

    Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort – the OxQUIP study.

    M. Pereira, C. Antoniades (Oxford, United Kingdom)

    Objective: We aimed to determine longitudinal changes in motor and cognitive features of Progressive Supranuclear Palsy using multiple closely spaced follow-up timepoints over a period…
  • MDS Virtual Congress 2020

    Automated pattern based classification in neuropathology proven parkinsonism

    K. Schindlbeck, D. Gupta, C. Tang, S. O'Shea, K. Poston, V. Dhawan, J.P Vonsattel, S. Fahn, D. Eidelberg (New York, NY, USA)

    Objective: In patients with parkinsonism and uncertain differential diagnosis, an automated image-based algorithm can help to distinguish idiopathic Parkinson’s disease (IPD) from atypical parkinsonian syndromes…
  • MDS Virtual Congress 2020

    The Progressive Supranuclear Palsy Clinical Deficits Scale

    G. Respondek, I. Piot, K. Schweyer, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, T. Stebbins, G. Höglinger (Hannover, Germany)

    Objective: To develop a scale to monitor clinical deficits in patients with Progressive Supranuclear Palsy across its broad phenotypes. Background: There is currently no undisputed,…
  • MDS Virtual Congress 2020

    Automated classification of neurodegenerative parkinsonian syndromes using multimodal magnetic resonance imaging in a clinical setting

    L. Chougar, J. Faouzi, N. Pyatigorskaya, O. Colliot, S. Lehéricy (Paris, France)

    Objective: To evaluate the accuracy for the categorization of parkinsonian syndromes of a machine learning algorithm trained with a research cohort and tested on an…
  • MDS Virtual Congress 2020

    Chromogranin B in cerebrospinal fluid as a novel biomarker for Progressive supranuclear palsy

    H. Takigawa, R. Sakata, T. Inoue-Nishida, H. Kowa, K. Namashima, R. Hanajima (Yonago, Japan)

    Objective: To identify the biomarker associated with progressive supranuclear palsy (PSP) for better understanding of a pathophysiology and clinical diagnosis. Background: PSP is one of…
  • MDS Virtual Congress 2020

    Clinical features and natural course of corticobasal degeneration and progressive supranuclear palsy presenting as corticobasal syndrome

    I. Aiba, M. Yoshida, T. Shimohata, Y. Hayashi, T. Sano, Y. Saito, S. Murayama, K. Hasegawa, Y. Iwasaki, M. Sakai, K. Wakabayashi, T. Komori, K. Nakashima (Nagoya, Japan)

    Objective: To compare clinical features and natural course of corticobasal degeneration (CBD) presenting as corticobasal syndrome (CBD-CBS) and progressive supranuclear palsy presenting as corticobasal syndrome…
  • MDS Virtual Congress 2020

    Gait initiation in patients with Progressive Supranuclear Palsy: a biomechanical and FDG-PET study

    M. Todisco, C. Palmisano, G. Marotta, C. Pacchetti, G. Pezzoli, I. Isaias (Würzburg, Germany)

    Objective: To define the brain metabolic abnormalities related to gait initiation (GI) failure in subjects with Progressive Supranuclear Palsy (PSP). Background: PSP is an atypical…
  • MDS Virtual Congress 2020

    Glucocerebrosidase activity and atypical parkinsonism: a multi-centre exploratory study

    R. Alvarez Velasco, P. Giraldo, P. Irun, L. Vela Desojo, L. Lopez Manzanares, J.M Arbelo González, M. Eimil Ortiz, A. Rojo Sebastian, M. Mata Álvarez-Santullano, I. Martínez Torres, J. Garcia-Caldentey, M. Gómez Gutierrez, C. Estévez-Fraga, J.L López Sendón, G. García Ribas, J.C Martínez Castrillo, A. Alonso-Canovas (Madrid, Spain)

    Objective: We aimed to determine the frequency of Glucocerebrosidase (GBA) deficiency (subclinical Gaucher's Disease type 1, GD1) in patients with atypical parkinsonism (AP) with features…
  • MDS Virtual Congress 2020

    Long and short survival in Parkinson syndrome: pathology and genetics are key prognostic factors

    A. Rajput, C. Robinson, M. Farrer, E. Gustavsson, A. Rajput (Saskatoon, SK, Canada)

    Objective: To study the clinical, pathological and genetic profile of Parkinson syndrome (PS) cases that have > 20 years survival (long survival, or LS) compared…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 49
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley